University of Massachusetts

Lipid nanoparticle mRNA vaccine
#Cancer research #Cancer vaccine #University of Massachusetts

Nanoparticle-based vaccine could prevent cancer tumours

A nanoparticle-based vaccine developed by the University of Massachussets Amherst could effectively prevent melanoma, pancreatic and triple-negative breast cancer, the university reveals.  Scientists tested the vaccine in mice, with 88% remaining tumour-free. The results also show that the vaccine reduced, and in some cases prevented, the spread… Read More

#News

Monoclonal antibodies
#Monoclonal antibodies #Multiple sclerosis #Phase II trial #Tiziana Life Sciences #University of Massachusetts

UMass joins Phase II trial for multiple sclerosis

The University of Massachusetts (UMass) has begun dosing participants with Tiziana Life Sciences’ lead development candidate, intranasal foralumab, as part of an ongoing Phase II trial in patients with non-active secondary progressive multiple sclerosis (na-SPMS). UMass joins Brigham and Women’s Hospital (BWH), Yale Multiple Sclerosis Center, and Johns… Read More

#News